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ABSTRACT
The binding of hyaluronate to SV-3T3 cells was measured by incubating a
suspension of cells (released from the substratum with EDTA) with 3H-labeled
hyaluronate and then applying the suspension to glass fiber filters which retained
the cells and the bound hyaluronate . The extent of binding was a function of both
the concentration of labeled hyaluronate and the cellnumber . Most ofthe binding
took place within the first 2 min of the incubation and was not influenced by the
presence or absence of divalent cations . The binding of labeled hyaluronate to
SV-3T3 cells could be prevented by the addition of an excess of unlabeled
hyaluronate . High molecular weight preparations of hyaluronate were more
effective in preventing binding than low molecular weight preparations . The
binding of [3H]hyaluronate was inhibited by high concentrations of oligosaccha-
ride fragments ofhyaluronate consisting of six sugars or more, and by chondroitin .
The sulfated glycosaminoglycans (chondroitin-4-sulfate, chondroitin-6-sulfate,
dermatan sulfate, heparin, and heparan sulfate) had little or no effect on the
binding . The labeled hyaluronate bound to the cells could be totally removed by
incubating the cells with testicular hyaluronidase, streptomyces hyaluronidase, or
trypsin, indicating that the hyaluronate-binding sites are located on the cell
surface .
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Hyaluronate has been implicated in a number of
phenomena in vivo which involve cell-to-cell in-
teractions. Studies of a variety of systems have
revealed a very close correlation between the pres-
ence oflarge amounts of hyaluronate in the extra-
cellular matrix and the migration of cells through
the matrix . Examples include : developing embry-
onic tissues such as the cornea (24), vertebral
column (19), neural crest (3, 11), heart (9) and
primary mesenchyme (15), as well as amphibian
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limb regeneration (22) and mammalian tissue re-
modeling (4, 8, 10) . In virtually all ofthese systems,
it has been demonstrated also that subsequent
cessation of migration and onset of differentiation
are associated with a dramatic decrease in extra-
cellular hyaluronate concentration . Consequently,
it has been proposed that hyaluronate acts to
weaken cell-to-cell adhesion and thereby facilitate
migration (see reference 21 for review) .
Studies in vitro have also implicated hyaluro-
nate in cell-to-cell interactions . Toole et al. (23)
have shown that when small amounts of hyaluro-
nate are added to cultures of dissociated somite
475cells (stage-26 chick embryo), the subsequent ap-
pearance of cartilage nodules is inhibited . In ad-
dition, Corsin (2) has demonstrated hyaluronate-
induced inhibition ofchondrogenesis in organ cul-
tures of amphibian cephalic neural crest recom-
bined with endoderm and mesoderm . Possibly, the
exogenous hyaluronate is preventing specific
adhesion of the prechondrogenic cells .
Recently, evidence was presented which
strongly suggests binding of hyaluronate to the
surface of cells (26) . The aggregation of SV-3T3
cells, and several other types of cultured mouse
cells, hasbeen found to consist oftwocomponents,
one dependentupon and theother independent of
the presence of divalent cations (17, 26) . The latter
component was found to be blocked by several
enzymes which degrade hyaluronate, including
streptomyces hyaluronidase which is specific for
this polysaccharide . The divalent-cation-inde-
pendent aggregation was also inhibited by high
concentrations of exogenously added hyaluronate,
chondroitin, and oligosaccharide fragments of hy-
aluronate consisting of six sugars or more . Other
sulfated glycosaminoglycans had little or no effect
on aggregation . These results have been inter-
preted to mean that the divalent-cation-independ-
ent aggregation is mediated by the interaction
between endogenous hyaluronate on one cell and
hyaluronate-binding receptors on adjacent cells .
This interactionwouldthen be prevented by either
destroying the endogenous hyaluronate with en-
zymes or by saturating the binding sites with ex-
ogenous hyaluronate (26) .
In the present study, binding of radioactively
labeled hyaluronate to the surface of SV-3T3 cells
is directly demonstrated . The results of this study
suggest the presence of receptor sites identical to
those that mediate the divalent-cation-independ-
ent aggregation of cells .
MATERIALS AND METHODS
Culture Procedures
The SV-3T3 cell line was obtained from Dr . J . Keller,
and rat fibrosarcoma cells from Dr . A. Dorfman . The
cells were grown on 100-mm Falcon plastic dishes (Fa-
konLabware, Div . of Becton, Dickinson& Co ., Oxnard,
Calif .) in Dulbecco's Modified Eagle's Medium (18)
containing 10% fetal calfserum plus 103 U/ml penicillin
G and 100 pg/ml streptomycin . All cultures were main-
tained in a 5% CO 2-air atmosphere, and the medium was
changed every 2 or 3 d .
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Isolation of 3H-Labeled Hyaluronate
Foreach preparation, 12 dishes of confluent rat fibro-
sarcoma cells were grown in the presence of 250 pCi/ml
of [3H]acetate (New England Nuclear, Boston, Mass ., 6
Ci/mmol, or Amersham Corp ., Arlington Heights, Ill .,
2 Ci/mmol) for 2 d . The medium was collected and
digested with 1.0 mg/ml pronase at 37°C in the presence
of 0.02% sodium azide. The solution was then exhaus-
tively dialyzed against saline followed by distilled water .
Hyaluronate was isolated by cetylpyridinium chloride
precipitation . For this, the solution wasmade 0.03M in
NaCl and a small quantity of celite was added . A 10%
solution of cetylpyridinium chloride was then added
dropwise until no further precipitate was formed . After
centrifugation, the precipitate was extracted twice in a
small volume of 0.1% cetylpyridinium chloride in 0.4 M
NaCl . The hyaluronate was then precipitated by the
addition of4 vol of ethanol to the combined extracts at
4°C . After centrifugation, the pellet was washed several
times with 100% ethanol and dissolved in distilled water .
Some preparations (preps . 2 and 3) were further pu-
rified by ion-exchange chromatography . The solution of
hyaluronate was applied to a 1.5 x 10 cm column of
DEAE-cellulose (Whatman DE-52) and eluted with a
linear gradient of 0.02M Tris, pH 7.5 (250 ml) to 1.0 M
NaCl, 0.02 M Tris, pH 7.5 (250 ml), collecting 5-ml
fractions. The fractions containing the hyaluronate were
pooled, concentrated, and dialyzed against saline.
Greater than 98% of the recovered label was associated
with the hyaluronate peak, andno detectable amount of
label was associated with other glycosaminoglycan frac-
tions. Omission of the DEAE-cellulose chromatography
step (prep. 1) did not significantly alter the results . The
uronic acid content of the various preparations of hya-
luronate was determined by the method of Bitter and
Muir (1) .
The specific activities of the various preparations of
[3Hlhyaluronate used in this study are : prep. l, 6.5 x 10'
cpm/mg hyaluronate; prep . 2, 1 .1 x 108 cpm/mg ; prep .
3, 1 .0 x 108cpm/mg .
Viscosity Measurements
The intrinsic viscosity (rl) was determined with a
Cannon 75K 511 dilution viscometer (Cannon Instru-
ment Co ., State College, Pa .) having a buffer flow time
of 112 s at 25°C . All measurements were done in 0.2M
NaCl, 0.02 M Tris, pH 7.5, and at least four dilutions
were tested. The concentration of hyaluronate was de-
termined by uronic acid assay (1) using glucuronolactone
as a standard . The amount of sodium hyaluronate was
obtained by multiplying the mass of glucuronolactone
by a factor of 2.27 . Approximate estimates of molecular
weight can be calculated from these viscosity values
using the equation il (100 ml/g) = (2.28 x 10-')mol
wt
0 .818
(13) .Binding Assay
TheSV-3T3 cells were subcultured at approx . l x 106
cells per 100-mm plate and allowed to grow for 24 h
before each experiment . The plates were rinsed twice
with calcium and magnesium-free phosphate-buffered
saline (CMF-PBS), and then 8 ml of 0.02% solution of
EDTA inCMF-PBSwasadded . After 10 min theEDTA
solution wasremoved, the plates were gently rinsed three
times with CMF-PBS, and the cells were suspended in a
measured amount ofCMF-PBS by flushing with a Pas-
teur pipette . The concentration of suspended cells was
determined with ahemocytometer .
1-ml aliquots of the cell suspension (approx . I x 10 6
cells) were then added to siliconized conical flasks (25
ml) containing labeled hyaluronate and the various
agents to be tested. Unless indicated otherwise, the flasks
were shaken at 70 rpm for 15 min at room temperature .
A 1-ml aliquot was then removed from each flask with
a plastic pipette (Falcon Labware) and applied to glass
fiber filters (Whatman 934 AH) on a Millipore filter
manifold (Millipore Corp ., Bedford, Mass.), followed by
thorough washing withCMF-PBS . The filters were dried
under a heat lamp, placed in 10 ml of Aquasol (New
England Nuclear), andthe radioactivitywasdetermined
in a scintillation counter .
All values represent theaverage of either duplicate or
triplicate determinations minus the nonspecific back-
ground . Unless specified otherwise, the background was
determined as the amount of label retained on the filters
in the absence of cells . In some specified cases, back-
ground was measured as the amount retained on the
filters in the presence of cells plus a large excess of
unlabeled hyaluronate (1.0 mg/ml; mol wt, 2.0 x 105 ) .
The backgrounds determined by the two methods were
similar and varied from 15 to 40% of the total counts
retained by 1-2 x 106 cells, depending upon the partic-
ular batch of [ 3H]hyaluronate . In most cases, the [3H]-
hyaluronate was centrifuged (75,000 g, 60 min) before
thebinding assay, which considerably reduced theback-
ground.
Identification ofHyaluronate
Samples of [3H]hyaluronate were digested with chon-
droitinase ABC(1 U/ml) in 0.1 M Tris buffer,pH 7.5 at
37°C for 5 h, then mixed with disaccharide standards
and aliquots applied to thin-layer chromatography sheets
(plastic-backed cellulose, 30x 20 cm; Merck&Co., Inc.,
Rahway, N. J.) . The samples were desalted overnight
using n-butanol-ethanol-water (52:32:16), dried, and the
chromatogram was developed with n-butanol-acetic
acid-IM ammonia (2 :3:1) for 8 h (27). The chromatog-
raphy sheet was dried and the disaccharide spots were
visualized under UV light. The sheet was then cut into
small sections and the radioactivity in each wascounted
using a cocktail of Omnifluor (New England Nuclear)
dissolved in toluene . Each section was then washed by
dipping in toluene, dried, and the cellulose was scraped
into atube for N-acetylhexosamine assay by themethod
of Reissig et al . (12) . The cellulose was removed by
centrifugation before measurement in the spectropho-
tometer .
The purity of the [3H]hyaluronate as measured in this
manner is demonstrated in Fig . la . At least 95% of the
total radioactivity corresponds to the position of the
hyaluronate-derived disaccharide produced by chondro-
itinase ABCdigestion .
Samples of labeled material derived from the cell-
binding experiments were first precipitated with 3 vol of
1.3%potassium acetate in 95%ethanol at 4°Covernight,
then redissolved in asmall volume of0.1 M Tris buffer,
pH 7.5 for chondroitinase digestionandchromatography
with internal standards as described above . At least 90%
of the labeled material from these experimentswas pre-
cipitated and redissolved in theabove step .
Materials
Two preparations of hyaluronate, both from human
umbilical cord, were used . The first, obtained from Dr.
Martin Mathews, hada viscosity of450ml/g correspond-
ing to a mol wt of approx . 2.0 x 105 ; the second, from
Drs. E . A. Balazs and B. Jacobson, had a viscosity of
3,800 ml/g corresponding to a mol wt of approx. 2.5 x
106 . The oligosaccharide fragments of hyaluronate were
prepared as described previously (26). Dermatan, der-
matan sulfate, heparin, and heparan sulfate were do-
nated by Dr. Martin B . Mathews, chondroitin (desulfated
chondroitin-6-sulfate) by Dr. Allen L . Horwitz . Chon-
droitin-4-sulfate, chondroitin-6-sulfate, chondroitinase
ABC, chondro-4-sulfatase, and streptomyces hyaluroni-
dase were purchased from Miles Laboratories, Inc . (Elk-
hart, Ind.); the testicular hyaluronidase (typeVI-S) from
SigmaChemical Co. (St . Louis, Mo .); and Trypsin(TRT
PCK) from Worthington Biochemical Corp . (Freehold,
N. J.) . The unsaturated disaccharides, 2-acetomido-2-
deoxy-3-O (,Q-D-gluco-4-enepyranosyluronic acid)-D-
glucose(Di-O-HA), 2-acetomido-2-deoxy-3-O- (,(3-D-
gluco-4-enepyranosyluronic acid)-4-O-sulfo-D-galactose
(DI-4-S), and 2-acetomido-2-deoxy-3-O- (/3-D-gluco-4-
enepyranosyluronicacid)-6-O-sulfo-D-galactose (Di-6-S)
were prepared by digestion of hyaluronate, chondroitin-
4-sulfate and chondroitin-6-sulfate respectively with
chondroitinase ABC. The 2-acetomido-2-deoxy-3-O (,Q-
D-gluco-4-enepyranosyluronic acid)-D-galactose (Di-O-
Ch)wasprepared by digesting chondroitin-4-sulfate con-
currently with chondroitinase ABC and chondro-4-sul-
fatase (14).
RESULTS
Binding of [3H]Hyaluronate to SV-3T3 Cells
Subconfluent SV-3T3 cells were removed from
tissue culture dishes with EDTA, incubated with
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FIGURE 1
￿
Thin-layer chromatography of chondroiti-
naseABC digests of (a) purified [3H]hyaluronate and (b)
[3H]hyaluronate bound to SV-3T3 cells. (a) Purified
[3H]hyaluronate (prep . 3) was processed directly as de-
scribed in Materials and Methods. (b) [3H]hyaluronate
bound to SV-3T3 cells was recovered by the following
procedure : SV-3T3 cells were incubated with [3H]hya-
luronate (2 ug/ml, prep. 3) for 15 min and then applied
to glass fiber filters which were thoroughly washed with
CMF-PBS . The filters were then transferred to different
ports on the manifold filter box and each was treated
with a total of 4 ml of 0.5 mg/ml trypsin (TPCK) in
CMF-PBS which was added at 15-min intervals over a
period of 60 min . The filters were then washed with
CMF-PBS . The filtrates from these steps (trypsin plus
wash) were pooled, dialyzed against distilled water, and
lyophilyzed . The trypsin treatment removed essentially
all of the label from the filters and at least 90% of this
was recovered after the dialysis and lyophilization steps .
The sample was then processed as described in Materials
and Methods . The brackets indicate the positions of the
various disaccharide standards as they were visualized
by UV light . Using these spots as a guide, the chromat-
ogram was cut into sections which were then analyzed
for label and N-acetylhexosamine content . The di-4-S
disaccharide yields no color in the N-acetylhexosamine
assay .
varying concentrations of [3H]labeled hyaluronate,
and then filtered . As shown in Fig. 2, the amount
of hyaluronate bound increased with increasing
concentration of input hyaluronate up to 2-3 pg/
478
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 82, 1979
FIGURE 2
￿
Effect of increasing concentrations of [3H]-
hyaluronate on the binding of hyaluronate to SV-3T3
cells . (a) Prep. 1 . [3H]hyaluronate was incubated with
0.93 X 106 cells/ml. (b) Prep . 2 . [3H]hyaluronate was
incubated at 1.2 x 106 cells/ml . The background was
subtracted from each value. The absolute amount of
hyaluronate bound was calculated from the respective
specific activities (prep . I, 6.5 x 10 7 cpm/mg ; prep . 2,
1 .1 X 10 6 cpm/mg) .
ml. At this concentration, the binding sites on the
cells appeared to be saturated with hyaluronate.
The three preparations of [3H]hyaluronate used
in this study saturated thebinding sites at approx-
imately the same concentration (1-3 p.g/ml) . How-
ever, the fraction of hyaluronate which bound to
the cells varied widely for other preparations . For
preparations of [3H]hyaluronate used in this study
(preps. l, 2, 3), from 0.4 to 0.6% ofthe input counts
were bound by 1 x 106 SV-3T3 cells at 1 pg/ml of
input hyaluronate . However, for other prepara-
tions which were not used in this study, this pro-
portion was as small as 0.01% . Also, for a given
preparation of [3H]hyaluronate, there was a grad-
ual decrease in its binding activity with time of
storage .
Since only a small fraction of the input hyalu-
ronate was usually bound to the cells under the
conditions used, it was important to establish that
the bound label was, in fact, hyaluronate rather
than a contaminant in the preparation . This was
accomplished by releasing the cell-bound material
into solution with trypsin (0.5 mg/ml in CMF-
PBS for 30 min) and then analyzing it by chon-droitinase ABC digestion and thin-layer chroma-
tography as described in Materials and Methods .
Fig . 1 b shows that -80% of the bound label was
associated with the digestion products of hyalu-
ronate, the rest remaining at the origin . Similar
results were obtained for each preparation of
[3H]hyaluronate used in this study .
It is possible that only a small unique subfrac-
tion of the labeled hyaluronate bound to the cells.
To test this possibility, cells were incubated with
labeled hyaluronate and filtered . Then the filtrate
was used to test the ability of the remaining un-
bound hyaluronate to bind to a second set of SV-
3T3 cells . As shown in Table I, the cells bound
similar amounts of labeled hyaluronate from the
filtratesand from the original solution . Thus, there
does not appear to be a small subpopulation of
hyaluronate that preferentially binds to the cells.
Other characteristics of hyaluronate binding to
SV-3T3 cells were examined. First, the amount of
hyaluronatebound increased linearlywith increas-
ing cell number (Fig . 3) . Secondly, thetime-course
ofbinding (Fig . 4) showed that most of thebinding
took place within the first 2 minof the incubation
and that the amount of hyaluronate bound re-
mained relatively constant over a period of 1 h .
Finally, the presence or absence ofdivalent cations
had no effect on the binding of labeled hyaluro-
nate (Table 1I) .
Competition of Other Carbohydrate
Preparations
For competition experiments, the amount of
[3H]hyaluronate added was approximately the
minimum needed for saturation . For preps . 1 and
TABLE I
Effect ofPretreatment with Cells on the Binding of
[3H]Hyaluronate to SV-3T3 Cells
Hyaluronate
￿
cpm Bound ± SD
Control
￿
568 ± 51
Pretreated
￿
561 ± 34
1 3H]hyaluronate (6 ug/ml; prep . 2) was mixed with 3 .0
x 106 SV-3T3 cells/ml. After 15 min, the cell suspension
was filtered and the filtrate collected . The washed filter
retained 2835 cpm of bound hyaluronate . Aliquots of a
suspension of untreated SV-3T3 cells were then mixed
with aliquots of the filtrate containing the residual
[ 3H]hyaluronate or of the original [3H]hyaluronate solu-
tion. The final mixtures contained 0.85 x 106 cells/ml
and 3 Itg/ml hyaluronate. After 15 min the cell suspen-
sions were again filtered . The background was 163 cpm .
0 2 4 6 8 10 12 14 16 18
Cell number x10-5/m I
FIGURE 3
￿
Effect of increasing SV-3T3 cell number on
the binding oflabeled hyaluronate. Cells were incubated
for 15 min with 3wg/ml of prep . 2, [3H]hyaluronate . The
background was 164 cpm .
0 10 20 30 40 50 60
Time . min
FIGURE 4
￿
Time-course of [3H]hyaluronate binding to
SV-3T3 cells . Labeled hyaluronate (3 tag/ml, prep . 2)
was incubated with 7 x 10 5 cells/ml for varying lengths
of time . The background was 160 cpm .
TABLE II
Effect ofDivalent Cations on the Binding of[3H]-
Hyaluronate to SV-3T3 Cells
Component added
￿
cpm Bound ± SD
-
￿
636 ± 69
Ca++, Mg-
￿
623 ± 26
Mixtures contained 3 hg/ml of [3H]hyaluronate (prep . 2)
and 1 .2 x 106 cells/ml . One set of mixtures was made
0 .9 mM in CaC1 2 and 0.5 mM in MgC12 . Background
was 160 cpm .
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greater extent, this was 1 leg/ml .
In initial experiments with unlabeled hyaluro-
nate as thecompetitor, it was found that the order
of addition of the components, i.e., labeled hya-
luronate added to the cells first, then theunlabeled
hyaluronate (or vice versa) had no significant ef-
fect on the final extent of binding (data not
shown). For this reason, in all subsequent experi-
ments the [3H]hyaluronate and the competitor
were added to the cells simultaneously and then
incubated for 15 min .
Competition of [3H]hyaluronate binding with
unlabeled hyaluronate was dependent upon mo-
lecular weight. The concentration of high molec-
ular weight hyaluronate (2.5 x 10) necessary for
50o11o inhibition of [3H]hyaluronate binding was ^-5
leg/ml (Fig. 5 a) which was 10- to 20-fold less than
that of the lower molecular weight (2.0 x 10)
preparation of hyaluronate (Fig . 5b and c) . It
should be noted that the absolute amount of
hyaluronate required for500 7c inhibition ofbind
varied slightly for different preparations of [3H]-
hyaluronate. However, the relative competitive ef-
ficiencies of the high and low molecular weight
preparations of hyaluronate remained constant .
a
2
( o zo ao o
hyaiuronate (o, hexasaccharide ) added . a/mi
FIGURE 5 Effect of varying concentrations of unla-
beled hyaluronate and hexasaccharide on the binding of
labeled hyaluronate to SV-3T3 cells . In each case 3 jig/
ml of prep . 1, [3H]hyaluronate was used . (a) 9 x 105
cells/ml with hyaluronate, mol wt: 2.5 x 106. (b) 2.2 x
10' cells/ml with hyaluronate, molwt : 2 .5 x 106 (") and
hyaluronate, mol wt: 2.0 x 105 (0) . (c) 1.6x 106 cells/ml
with hyaluronate, molwt : 2 .5 x 106 (") and hyaluronate,
mol wt : 2.0 x 10 5 f). (d) 2 .2 x 106 cells/ml with
hyaluronate, mol wt : 2 .0 x 105 (") and hexasaccharide
fragment of hyaluronate ("). The backgrounds for the
various experiments were: (a) 259 cpm, (b) 689 cpm, (c)
550 cpm, (d) 757cpm .
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Because of this large effect of molecular weight,
we measured the viscosity of [3H]hyaluronate pre-
pared from cultures of rat fibrosarcoma cells in
the same fashion as the preparations used here for
the binding studies. The viscosity obtained was
3,300 ml/g, which corresponds to a mol wt of
approx. 2.0 x 106 , almost identical to the high
molecular weight preparation used for the preced-
ing competition experiments.
The hexasaccharide fragment of hyaluronate
also competed with labeled hyaluronate for bind-
ing but was even less efficient than either prepa-
ration of intact hyaluronate (Fig . 5 d) . The ef-
fect of various hyaluronate oligosaccharides at a
concentration of 5 mg/ml on the binding of
[3H]hyaluronate is given in Table III. The disac-
charide had no effect and the tetrasaccharide had
only a slight inhibitory effect, whereas the hexa-
saccharide and larger oligosaccharides signifi-
cantly inhibited binding of labeled hyaluronate .
Chondroitin is a glycosaminoglycan similar in
structure to hyaluronate except that it coat
acetylgalactosantine instead of N-acetylglucosa-
mine . Chondroitin also inhibited the binding of
labeled hyaluronate to SV-3T3 cells (Fig. E), but
its activity (500 leg/ml for 50% inhibition) was less
than that of thelow molecularweight prepar
of hyaluronate (Fig . 5 c) and similar to that of the
hexasaccharide (Fig. 5d).
Dermatan has a structure similar to that of
chondroitin except that it contains iduronic acid
instead of glucuronic acid. The particular prepa-
ration of dermatan used in this study contained
-80% iduronic acid and 20% glucuronic acid.
When tested in the competition assay (Table IV),
it was found to be distinctly less active than a
TABLE III
Inhibition of[3H]Hyaluronate Binding to SV-3T3
Cells by Oligosaccharide Fragments ofHyaluronate
Mixtures contained ( leg/ml of [3H]hyaluronate (prep. 3)
plus 5 mg/ml of oligosaccharide, incubated with 1 .8 x
106 SV-3T3 cells/ml for 15 min . The cells were then
filtered, washed, and counted. The background was 160
cpm .
Component added Inhibition
- 1,005 ± 38 0
Disaccharide 973 ± 54 3
Tetrasaccharide 644 ± 80 36
Hexasaccharide 322 ± 14 68
Octasaccharide 291 t 72 71
Decasaccharide 259 t 65 740 1 2 3 4 5
`J
￿
Chondroitin added, mg/ml
FIGURE 6
￿
Effect ofvarying concentrations of chondro-
itin on the binding of [3H1hyaluronate to SV-3T3 cells .
Increasing amounts of chondroitin were incubated with
31tg/ml prep . 2, [ 3H]hyaluronate and 1.3 x 106 cells/ml .
Heparan sulfate
￿
392 ± 10
￿
39
Heparin
￿
370 ± 31
￿
43
Mixtures contained 31Ag/ml of [3H]hyaluronate (prep . 2)
and 1.0 mg/ml of the various glycosaminoglycans . The
cell numbers were : exp 1, 1.12 x 106 cells/ml; exp 2, 1 .3
x 106 cells/ml ; and exp 3, 1.04 x 106 cells/ml . The
backgrounds were determined from the amount of label
retained on the filters in the presence of 1 mg/ml hya-
luronate . They were: exp 1, 204 cpm ; exp 2, 208 cpm;
and exp 3, 217 cpm .
similar amount of chondroitin . The sulfated gly-
cosaminoglycans chondroitin-4-sulfate, chondro-
itin-6-sulfate, and dermatan sulfate had a negligi-
ble effect on the binding of hyaluronate to SV-
3T3 cells, while heparin and heparan sulfate had
a small but consistent inhibitory effect (Table IV) .
Location ofBound Hyaluronate
To determine whether the bound hyaluronate
was intracellular or located on the cell surface,
cells were incubated with labeled hyaluronate for
15 minand then hyaluronidase (testicular or strep-
tomyces) was added to the suspension . After an
additional 15 min, the cells were filtered and
washed . As shown in TableV, both hyaluronidase
preparations eliminated essentially all of the
bound label .
Small amounts of trypsin also inhibited the
bindingoflabeled hyaluronate to cells (Table VI) .
These results are consistent with the cell surface
location of the hyaluronate-binding site and sug-
gest that this site may be a protein .
DISCUSSION
The major conclusion which can be drawn from
[3H]hyaluronate (3 1Ag/ml, prep . 2) was incubated with
SV-3T3 cells (1 .5 x 106 cells/ml and 1 .1 x 106 cells/ml
forexps 1 and 2, respectively) . After 15 min, the indicated
amount of either testicular or streptomyces hyaluroni-
dase was added to the suspensions. After 15 additional
min, the cells were filtered and the amount of bound
label was determined . The backgrounds were 160 and
58 cpm for exps I and 2, respectively .
TABLE VI
Effect of Trypsin on the Binding of 13HIHyaluronate
to SV-3T3 Cells
SV-3T3 cells (0.82 x 106 cells/ml) were added to flasks
containing both [3H]hyaluronate (1 Itg/ml, prep . 3) and
varying amounts ofTPCK trypsin . After incubating for
15 min, the cells were filtered, washed, dried, and
counted . The background was 152cpm .
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The
Inhibition
background was 160 cpm.
TABLE IV
of1 3H1Hyaluronate Binding to SV-3T3
Cells by Various Glycosaminoglycans
TABLE V
Effect of Testicular and Streptomyces
Hyaluronidases on the Binding of l3HJHyaluronate
to SV-3T3 Cells
% In- Exp % De-
Exp cpm Bound ± hibi- No. Component added cpm Bound ± SD crease
No . Component added SD tion 1 - 1,578 ± 289 0
1 - 495t 13 0 1 jig/ml Testicular 11 ± 43 99
Chondroitin 54 ± 24 89 hyaluronidase
Dermatan 245± 26 50 10 Itg/ml Testicular -32 ± 42 102
hyaluronidase
2 - 425 ± 35 0
Chondroitin-4-sulfate 367 t 39 19 2 - 916±30 0
Chondroitin-6-sulfate 385 ± 4 15 l U streptomyces hy- I ± 12 100
Dermatan sulfate 358 ± 15 21 aluronidase
10 U streptomyces 19 ±25 98
3 - 653 ± 17 0 hyaluronidase
Trypsin added
'<x
cpm Bound ± SD % Decrease
0 665 t 58 0
0.1 597 ± 110 10
1 .0 57 ± 14 91
10 -39 ± 12 106these experiments is that hyaluronate binds to the
surface of SV-3T3 cells. Much of the evidence
suggests that this binding is due to specific recep-
tors on the cell surface. First, the binding oflabeled
hyaluronate to the cells is saturable and is in-
hibited by addition of unlabeled hyaluronate but
not by several other closely related carbohydrates.
Secondly, the binding can be prevented by incu-
bating the cells with low concentrations oftrypsin,
which presumably digests the receptors and
thereby stops binding. Thirdly, the binding of
labeled hyaluronate can be blocked by fragments
of hyaluronate consisting of six or more monosac-
charides, but not by smaller oligosaccharides, sug-
gesting that there is a minimum size requirement
for recognition by the putative receptor site. Fi-
nally, calculation of the dissociation constant for
binding of hyaluronate to the SV-3T3 cells gives
values in the range 1-2 x 10-9 M indicating a
relatively high-affinity interaction . We have also
calculated from our data that approx . 3 x 10 3
molecules of hyaluronate (mol wt, 2 x 106) bind
to each SV-3T3 cell at saturation. It must be
emphasized, however, that, since binding seems to
be influenced greatly by the molecular weight of
the hyaluronate, absolute figures for dissociation
constant and the number of molecules bound will
vary accordingly .
Previous work indicated that the divalent-cat-
ion-independent aggregation of SV-3T3 cells, as
well as other cultured cell lines, is dependent on
the presence of intact endogenous hyaluronate
associated with their cell surfaces (26) . It is very
likely that the mechanism which is responsible for
binding hyaluronate is identical to that which
mediates the cation-independent aggregation of
cells. This is suggested by the very close correlation
between those substances which inhibited aggre-
gation and those which inhibited hyaluronate
binding . For example, macromolecular hyaluro-
nate and fragments of hyaluronate consisting of
six sugars or more were active in inhibiting both
aggregation and binding of [ 3H]hyaluronate to SV-
3T3 cells, while the tetrasaccharide fragment was
only slightly active and the disaccharide was not
active in either case . Likewise, chondroitin and, to
a lesser extent, dermatan were active in blocking
both aggregation and the binding of labeled hya-
luronate . On the other hand, the sulfated gly-
cosaminoglycans (chondroitin-4-sulfate, chondro-
itin-6-sulfate, dermatan sulfate, heparin, and hep-
aran sulfate) had little or no effect on either ag-
gregation or binding . In addition to the above
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characteristics, it was found that the presence of
calcium and magnesium did not affect the binding
of labeled hyaluronate, nor were they involved in
the hyaluronate-mediated aggregation of cells .
Several structural requirements for binding of
hyaluronate can be inferred from the competition
experiments . First, the fact that chondroitin is a
competitor for hyaluronate binding suggests that
polymersofN-acetylgalactosamine-glucuronate or
of N-acetylglucosamine-glucuronate can bind .
The lower efficiency of chondroitin for competi-
tion as compared to hyaluronate could be due to
either the low molecular weight ofthe chondroitin
(<5 x 104 daltons) or the higher affinity for N-
acetylglucosamine-containing polymers. Sec-
ondly, the very low competitive activity of der-
matan suggests that binding is less active for idu-
ronate than for glucuronate-containing polymers .
Indeed, the activity of the dermatan could be due
entirely to the 20% glucuronate found in the prep-
aration. Thirdly, the lack of competitive activity
of chondroitin-4- and 6-sulfate suggests that the
presence of a sulfate group on the polymer pre-
vents binding. Finally, the inhibitory effect of the
hexasaccharide fragment of hyaluronate but not
small oligomers suggests that the binding site re-
quires at least six sugars . This last result agrees
with the work ofTruppe et al . (25)who found that
the binding of labeled hyaluronate to hepatocytes
could be prevented by the addition of oligosaccha-
rides of hyaluronate consisting of six or more
sugars .
In other studies (5, 16, 20, 29), it has been shown
that the addition of exogenous hyaluronate de-
presses synthesis of chondroitin sulfate-proteogly-
can by chondrocytes derived from a variety of
sources . This reaction is presumably mediated by
the interaction of hyaluronate with the chondro-
cyte surface, but in this case the effect is not
obtained with oligosaccharides smaller than a dec-
asaccharide (28) . In addition, the formation of
aggregates of chondroitin sulfate-proteoglycan by
the interaction ofmonomer with hyaluronate re-
quires oligosaccharides no smaller than the deca-
saccharide (6, 7) . Thus, we can conclude that cell
surface proteoglycan is probably not the receptor
site for hyaluronate binding in the present study .
An important characteristic of the binding of
hyaluronate to the surface of SV-3T3 cells is the
influence of molecular weight of the polysaccha-
ride . Although the hexasaccharide fragment of
hyaluronate was found to inhibit binding of la-
beled macromolecular hyaluronate significantly,the efficiency of competition was very much less
than that of high molecular weight hyaluronate .
Also, the large difference in efficiency of compe-
tition between hyaluronate preparations of mot
wt, 2.0 x 105and 2.5 x 106, emphasizes this point .
One possible explanation for this phenomenon is
a cooperative effect caused by the binding of
hyaluronate to more than one receptor at a time
because of its repetitive structure . Perhaps, when
one molecule ofhyaluronate binds to one receptor,
this enhances the probability that the same mole-
cule will bind to a second receptor . Thus, the
larger the hyaluronate molecule, the more sites it
can attach to andthe more tightly it is bound. An
alternative explanation is that some structural fea-
ture of the high molecular weight hyaluronate
caused it to be bound to the cell surface more
strongly than low molecular weight hyaluronate .
Clearly, further research is needed to resolve this
issue .
The importance of molecular weight in deter-
mining the efficiency of binding might explain
some of the variations be different prepara-
tions of [3H]hyaluronate with respect to their ex-
tent of binding . In general, those preparations
whichwere isolated by the gentlest procedures and
which presumably have the highest molecular
weight were those that bound most efficiently to
the cells. It was also noted in this study that, fora
particular batchoflabeled hyaluronate, the extent
ofbinding gradually decreased with time . Perhaps
this effect is caused by slow breakdown of hyalu-
ronate occurring with repeated freezing and thaw-
ing of the preparation .
SV-3T3 cells were used throughout this study
because the results of the study on aggregation
indicated the possibility of hyaluronate-binding
sites on the surface ofthese cells (26) . Preliminary
studies indicate that many other cell types are also
capable of binding labeled hyaluronate to varying
degrees . This includes both established cell lines
(3T3, 3T6, BHK) as well as cells isolated directly
from embryonic chick brain and limb bud . The
significance of the differences between the various
cell lines with respect to the extent of hyaluronate
binding is not as yet clear, since the effect of
endogenous hyaluronate on binding is unknown .
We are currently investigating this question.
As described in the Introduction, hyaluronate is
a major component of the embryonic extracellular
matrix in which mesenchymal cells migrate and
proliferate . It is also present in areas of tissue
remodeling and regeneration . Determination of
the nature of binding of hyaluronate to cells in-
volved in these processes as well as to cells exhibit-
ing malignant properties should shed light on the
role of hyaluronate in controlof cell behavior .
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